Dr Lal PathLabs Ltd

Premium

Healthcare

01 November, 2017

TA Associates scores exit from healthcare portfolio firm

US-based private equity firm TA Associates has sold its entire stake in a healthcare portfolio firm with healthy returns, its ......

Premium

Healthcare

24 July, 2017

TA Associates scoring above-average return from another India portfolio firm

US-based private equity investor TA Associates has offloaded over two-thirds of its stake in an India portfolio firm en route ......

Premium

Healthcare

17 February, 2017

TA Associates partially exits PIPE portfolio firm with good returns

US-based private equity investor TA Associates has logged a partial exit from a publicly listed firm, more than a year ......

Premium

Healthcare

04 January, 2017

Dr Lal PathLabs set to acquire Ahmedabad-based diagnostics firm

Dr Lal PathLabs Ltd, India's first diagnostics chain to go public, has emerged as the frontrunner to acquire an Ahmedabad-based ......

Premium

Healthcare

30 December, 2016

OrbiMed seals deal with Kolkata diagnostic chain

Healthcare-focused private equity firm OrbiMed has closed a deal to invest in Suraksha Diagnostic Pvt Ltd for a minority stake, ......

Premium

Healthcare

20 June, 2016

Dr Lal PathLabs to play volume game, says CEO Manchanda

Gurgaon-based Dr Lal PathLabs Ltd is India's second-largest diagnostics chain. The company, backed by private equity firms TA Associates and ......

Premium

Healthcare

12 May, 2016

How Thyrocare plans to expand after blockbuster IPO

Diagnostics chain Thyrocare Technologies Ltd, which made a spectacular stock-market debut this week, plans to expand its network of labs ......